Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome
- Author
- HEALD, A. H1 2 ; KAUSHAL, K1 ; SIDDALS, K. W1 ; RUDENSKI, A. S1 ; ANDERSON, S. G1 ; GIBSON, J. M1
[1] Diabetes & Endocrinology, University of Manchester, Hope Hospital, Salford, United Kingdom
[2] Department of Medicine, Bishop Auckland Hospital, Co Durham, United Kingdom - Source
Experimental and clinical endocrinology & diabetes. 2006, Vol 114, Num 7, pp 371-376, 6 p ; ref : 28 ref
- ISSN
- 0947-7349
- Scientific domain
- Endocrinology; Nutrition, obesity, metabolic disorders
- Publisher
- Thieme, Stuttgart
- Publication country
- Germany
- Document type
- Article
- Language
- English
- Author keyword
- IGFBP cardiovascular disease metabolic syndrome type 2 diabetes
- Keyword (fr)
- Appareil circulatoire pathologie Diabète type 2 Endocrinologie Marqueur biologique Protéine liaison IGFBP X Syndrome Maladie cardiovasculaire Protéine liaison IGFBP2 Endocrinopathie Métabolisme pathologie
- Keyword (en)
- Cardiovascular disease Type 2 diabetes Endocrinology Biological marker Insulin like growth factor binding protein X Syndrome Cardiovascular disease Insulin-like growth factor binding protein 2 Endocrinopathy Metabolic diseases
- Keyword (es)
- Aparato circulatorio patología Diabetes de tipo 2 Endocrinología Marcador biológico Proteína enlace IGFBP X Síndrome Cardiovascular enfermedad Proteína enlace IGFBP2 Endocrinopatía Metabolismo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A28 Vertebrates: endocrinology
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B21 Endocrinopathies / 002B21E Endocrine pancreas. Apud cells (diseases) / 002B21E01 Diabetes. Impaired glucose tolerance / 002B21E01A Etiopathogenesis. Screening. Investigations. Target tissue resistance
- Discipline
- Endocrinopathies Vertebrates : endocrinology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18017522
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1055/s-2006-924320 
https://dx.doi.org/10.1055/s-2006-924320
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2006-924320\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:93:\"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome\";s:9:\"\u0000*\u0000jtitle\";s:50:\"Experimental and clinical endocrinology & diabetes\";s:9:\"\u0000*\u0000stitle\";s:31:\"Exp. clin. endocrinol. diabetes\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"114\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"371\";s:8:\"\u0000*\u0000epage\";s:3:\"376\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0947-7349\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HEALD\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:10:\"KAUSHAL, K\";i:1;s:13:\"SIDDALS, K. W\";i:2;s:14:\"RUDENSKI, A. S\";i:3;s:14:\"ANDERSON, S. G\";i:4;s:12:\"GIBSON, J. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:93:\"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2006-924320\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:93:\"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome\";s:9:\"\u0000*\u0000jtitle\";s:50:\"Experimental and clinical endocrinology & diabetes\";s:9:\"\u0000*\u0000stitle\";s:31:\"Exp. clin. endocrinol. diabetes\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"114\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"371\";s:8:\"\u0000*\u0000epage\";s:3:\"376\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0947-7349\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HEALD\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:10:\"KAUSHAL, K\";i:1;s:13:\"SIDDALS, K. W\";i:2;s:14:\"RUDENSKI, A. S\";i:3;s:14:\"ANDERSON, S. G\";i:4;s:12:\"GIBSON, J. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:93:\"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2006-924320\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2006-924320\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:93:\"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome\";s:9:\"\u0000*\u0000jtitle\";s:50:\"Experimental and clinical endocrinology & diabetes\";s:9:\"\u0000*\u0000stitle\";s:31:\"Exp. clin. endocrinol. diabetes\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"114\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"371\";s:8:\"\u0000*\u0000epage\";s:3:\"376\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0947-7349\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HEALD\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:10:\"KAUSHAL, K\";i:1;s:13:\"SIDDALS, K. W\";i:2;s:14:\"RUDENSKI, A. S\";i:3;s:14:\"ANDERSON, S. G\";i:4;s:12:\"GIBSON, J. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:93:\"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2006-924320\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:93:\"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome\";s:9:\"\u0000*\u0000jtitle\";s:50:\"Experimental and clinical endocrinology & diabetes\";s:9:\"\u0000*\u0000stitle\";s:31:\"Exp. clin. endocrinol. diabetes\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"114\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"371\";s:8:\"\u0000*\u0000epage\";s:3:\"376\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0947-7349\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HEALD\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:10:\"KAUSHAL, K\";i:1;s:13:\"SIDDALS, K. W\";i:2;s:14:\"RUDENSKI, A. S\";i:3;s:14:\"ANDERSON, S. G\";i:4;s:12:\"GIBSON, J. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:93:\"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2006-924320\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:93:\"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome\";s:9:\"\u0000*\u0000jtitle\";s:50:\"Experimental and clinical endocrinology & diabetes\";s:9:\"\u0000*\u0000stitle\";s:31:\"Exp. clin. endocrinol. diabetes\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"114\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"371\";s:8:\"\u0000*\u0000epage\";s:3:\"376\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0947-7349\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"HEALD\";s:10:\"\u0000*\u0000aufirst\";s:4:\"A. H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:10:\"KAUSHAL, K\";i:1;s:13:\"SIDDALS, K. W\";i:2;s:14:\"RUDENSKI, A. S\";i:3;s:14:\"ANDERSON, S. G\";i:4;s:12:\"GIBSON, J. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:93:\"Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome\";s:8:\"\u0000*\u0000place\";s:9:\"Stuttgart\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
